Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes
Mahsa Taghavi-Farahabadi, Mohammad Mahmoudi, Sara Soudi, Seyed Mahmoud Hashemi
Topics & Concepts
ARDSCytokine stormMicrovesiclesMedicineMesenchymal stem cellImmunologyInflammationStem cellLungDiffuse alveolar damageStem-cell therapyExosomeCytokineDiseasePathologyBiologyAcute respiratory distressmicroRNACoronavirus disease 2019 (COVID-19)Internal medicineInfectious disease (medical specialty)Cell biologyBiochemistryGeneExtracellular vesicles in diseaseCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19